Login to Your Account

Remicade Gaining Favor As IBD Therapy; Other Targets Explored

By Randall Osborne

Monday, June 2, 2003

When writer Jonathan Ames remarked in print that he suffered from "infuriated bowel syndrome," the remark might have been amusing but also was full of painful meaning - especially for the legions afflicted with the condition under its more common name: inflammatory bowel disease (IBD), consisting mainly of ulcerative colitis and Crohn's disease.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription